Market Cap | ₹11,963Cr |
ROE | 77.82% |
P/E Ratio(TTM) | 59.82 |
EPS(TTM) | 86.84 |
P/B Ratio | 46.54 |
Dividend Yield | 1.06% |
Industry P/E | 40.04 |
Book Value | 111.60 |
Debt to Equity | 0.11 |
Face Value | 10 |
Parent Organisation | Sanofi Consumer Healthcare India |
NSE Symbol | SANOFICONR |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Abbott India | NA (0.00%) | 45.62 | ||
GlaxoSmithKline Pharmaceuticals | NA (0.00%) | 49.39 | ||
Pfizer | NA (0.00%) | 28.96 | ||
Astrazeneca Pharma India | NA (0.00%) | 123.92 |